China approves its first domestically developed auditory brainstem implant
The NMPA approved an auditory brainstem implant from a Shanghai Ninth People's Hospital team for young children with severe inner ear malformations who cannot use a cochlear implant.
China’s National Medical Products Administration (NMPA) approved a domestically developed auditory brainstem implant on October 20, according to Chinese media citing the regulator. The device came from a team led by Professor Wu Hao at Shanghai Ninth People’s Hospital with an industry partner and went through the NMPA’s innovative device pathway. Its 16-contact electrode array sits on the brainstem’s cochlear nucleus and stimulates auditory neurons directly, bypassing the cochlea and auditory nerve. It is approved for children aged 2 to under 6 with prelingual deafness caused by severe inner ear malformations or a missing cochlear nerve, who cannot benefit from a cochlear implant. The reports cite a 96.67% overall effective rate at 12 months but do not give the trial size.
Reports describe it as China’s first approved implantable auditory neural interface.
Learn more: Cochlear implant · Neuroprosthetics